• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The International journal of pharmacy practice >Development and validation of criteria to identify medication-monitoring errors in care home residents
【24h】

Development and validation of criteria to identify medication-monitoring errors in care home residents

机译：制定和验证标准以识别敬老院居民中的药物监控错误

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Aim The identification of medication-monitoring errors requires a validated definition. This paper describes the development and validation of a definition which includes criteria for specific medicines to determine whether a medication-monitoring error has occurred in the care home setting. Setting Criteria were developed for older people (aged 65 years or older) living in care homes. Methods Criteria were developed by two clinical pharmacists using published guidelines. The criteria were divided into those relating to initiation of therapy and maintenance monitoring. The study steering group, made up of clinical pharmacists, a general practitioner (GP) and pharmacy academics, then reviewed the criteria and a consensus was achieved. The criteria were then reviewed by a sample of 21 GPs and 11 clinical pharmacists. The threshold for acceptance for each criterion was set at 70% by agreement of all participants.Key findings The definition of a medication-monitoring error was accepted as 'when a prescribed medicine is not monitored in the way which would be considered acceptable in routine general practice. It includes the absence of tests being carried out at the frequency listed in the criteria for each medicine, with tolerance of +50%'. Seventy per cent agreement was reached on all criteria for the initiation of therapy, except warfarin (69%), and on all criteria for maintenance monitoring, except penicillamine (63%) and potassium (63%).Conclusions To our knowledge, this is the first study to define a medication-monitoring error, and to determine and validate specific criteria to identify such errors in older people living in care homes.
机译：目的识别药物监控错误需要经过验证的定义。本文描述了定义的发展和验证，该定义包括特定药物的标准，以确定在家庭护理环境中是否发生药物监控错误。为居住在养老院中的老年人（65岁以上）制定了设置标准。方法标准是由两名临床药剂师使用已发布的指南制定的。这些标准分为与开始治疗和维持监测有关的标准。由临床药剂师，全科医生（GP）和药学学者组成的研究指导小组，然后审查了标准，并达成了共识。然后由21位GP和11位临床药剂师的样本对标准进行审查。经所有参与者同意，将每个标准的接受阈值设定为70％。主要发现药物监控错误的定义被接受为“当未按照常规常规方式认为可接受的方式对处方药进行监控时”实践。它包括没有以每种药物的标准中列出的频率进行测试，耐受性为+ 50％'。除华法林（69％）外，所有其他治疗标准均达到百分之七十，除青霉素（63％）和钾（63％）外，所有维持治疗标准均达百分之七十。第一项研究定义了药物监控错误，并确定并验证了特定标准以识别住在疗养院中老年人的此类错误。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号